Literature DB >> 23652101

A gut-heart connection in cardiometabolic regulation.

Alessia Buglioni1, John C Burnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23652101      PMCID： PMC4512286          DOI： 10.1038/nm.3196

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension.

Authors:  Alessandro Cataliotti; Lisa C Costello-Boerrigter; Horng H Chen; Stephen C Textor; John C Burnett
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.

Authors:  Marica Bordicchia; Dianxin Liu; Ez-Zoubir Amri; Gerard Ailhaud; Paolo Dessì-Fulgheri; Chaoying Zhang; Nobuyuki Takahashi; Riccardo Sarzani; Sheila Collins
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

3.  Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.

Authors:  B Wang; J Zhong; H Lin; Z Zhao; Z Yan; H He; Y Ni; D Liu; Z Zhu
Journal:  Diabetes Obes Metab       Date:  2013-03-20       Impact factor: 6.577

4.  Natriuretic peptides: a new lipolytic pathway in human adipocytes.

Authors:  C Sengenès; M Berlan; I De Glisezinski; M Lafontan; J Galitzky
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

Review 5.  Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct.

Authors:  T Inoue; H Nonoguchi; K Tomita
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

6.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

7.  A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

Authors:  Valentina Cannone; Guido Boerrigter; Alessandro Cataliotti; Lisa C Costello-Boerrigter; Timothy M Olson; Paul M McKie; Denise M Heublein; Brian D Lahr; Kent R Bailey; Maurizio Averna; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

8.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

9.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

10.  Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.

Authors:  Erik Ingelsson; Michael J Pencina; Geoffrey H Tofler; Emelia J Benjamin; Katherine J Lanier; Paul F Jacques; Caroline S Fox; James B Meigs; Daniel Levy; Martin G Larson; Jacob Selhub; Ralph B D'Agostino; Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690
View more
  7 in total

Review 1.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 2.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

Review 3.  Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).

Authors:  Wei Song; Hao Wang; Qingyu Wu
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

4.  Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-/- mice.

Authors:  Paul M Ryan; Lis E E London; Trent C Bjorndahl; Rupasri Mandal; Kiera Murphy; Gerald F Fitzgerald; Fergus Shanahan; R Paul Ross; David S Wishart; Noel M Caplice; Catherine Stanton
Journal:  Microbiome       Date:  2017-03-13       Impact factor: 14.650

Review 5.  Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.

Authors:  Ming Lyu; Yue-Fei Wang; Guan-Wei Fan; Xiao-Ying Wang; Shuang-Yong Xu; Yan Zhu
Journal:  Front Microbiol       Date:  2017-11-08       Impact factor: 5.640

6.  Direct cardiovascular effects of glucagon like peptide-1.

Authors:  Asfandyar Sheikh
Journal:  Diabetol Metab Syndr       Date:  2013-08-29       Impact factor: 3.320

Review 7.  Natriuretic Peptides: The Case of Prostate Cancer.

Authors:  Letizia Mezzasoma; Matthew J Peirce; Alba Minelli; Ilaria Bellezza
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.